VentriPoint Diagnostics Ltd.
VPTDF
Price:
$0.112
Market Cap:
$25.10M
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart...[Read more]
Industry
Medical - Devices
IPO Date
2010-09-22
Stock Exchange
PNK
Ticker
VPTDF
PE Ratio
[-5.60]
ROE
[1.36%]
Current Ratio
[0.28]
Dividend Yield
[0%]
Enterprise Value
[25.90M]
Dividend History
The ROE as of November 2024 (TTM) for VentriPoint Diagnostics Ltd. (VPTDF) is 1.36%
According to VentriPoint Diagnostics Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.36%. This represents a change of -1104.71% compared to the average of -135.86% of the last 4 quarters.
VentriPoint Diagnostics Ltd. (VPTDF) Historical ROE (quarterly & annually)
How has VPTDF ROE performed in the past?
The mean historical ROE of VentriPoint Diagnostics Ltd. over the last ten years is -129.70%. The current 1.36% ROE has changed -1152.39% with respect to the historical average. Over the past ten years (40 quarters), VPTDF's ROE was at its highest in in the March 2024 quarter at 128.88%. The ROE was at its lowest in in the December 2023 quarter at -652.12%.
Average
-129.70%
Median
103.96%
Minimum
-2568.15%
Maximum
561.60%
VentriPoint Diagnostics Ltd. (VPTDF) ROE by Quarter and Year
Discovering the peaks and valleys of VentriPoint Diagnostics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.30%
Maximum Annual ROE = 561.60%
Minimum Annual Increase = -159.10%
Minimum Annual ROE = -2568.15%
| Year | ROE | Change |
|---|---|---|
| 2023 | -2568.15% | 2.30% |
| 2022 | -107.01% | 129.79% |
| 2021 | -46.57% | -159.10% |
| 2020 | 78.80% | -41.44% |
| 2019 | 134.55% | -37.16% |
| 2018 | 214.13% | -5.97% |
| 2017 | 227.72% | 95.26% |
| 2016 | 116.62% | -79.23% |
| 2015 | 561.60% | 515.07% |
| 2014 | 91.31% | 72.79% |
VentriPoint Diagnostics Ltd. (VPTDF) Average ROE
How has VPTDF ROE performed in the past?
The current ROE of VentriPoint Diagnostics Ltd. (VPTDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-907.24%
5-year avg
-501.68%
10-year avg
-129.70%
VentriPoint Diagnostics Ltd. (VPTDF) ROE vs. Peers
How is VPTDF’s ROE compared to its peers?
VentriPoint Diagnostics Ltd.’s ROE is less than Manhattan Scientifics, Inc. (47.28%), greater than Cannabix Technologies Inc. (-78.37%), less than Accelerate Diagnostics, Inc. (131.18%), less than Venus Concept Inc. (444.07%), greater than NeuroPace, Inc. (-195.26%), greater than Delcath Systems, Inc. (-379.90%), greater than Surmodics, Inc. (-1.16%), less than ProSomnus, Inc. Common Stock (50.75%), greater than CVRx, Inc. (-89.06%), greater than Integra LifeSciences Holdings Corporation (1.24%), greater than Monogram Orthopaedics, Inc. (-109.96%), greater than Axonics, Inc. (-0.27%), greater than Nano-X Imaging Ltd. (-30.34%), greater than Medtronic plc (7.80%),
| Company | ROE | Market cap |
|---|---|---|
| 47.28% | $503.35K | |
| -78.37% | $34.54M | |
| 131.18% | $44.28M | |
| 444.07% | $3.15M | |
| -195.26% | $185.98M | |
| -379.90% | $301.57M | |
| -1.16% | $536.01M | |
| 50.75% | $8.18M | |
| -89.06% | $327.87M | |
| 1.24% | $1.87B | |
| -109.96% | $72.91M | |
| -0.27% | $3.60B | |
| -30.34% | $331.69M | |
| 7.80% | $114.54B |
Build a custom stock screener for VentriPoint Diagnostics Ltd. (VPTDF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VentriPoint Diagnostics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
VentriPoint Diagnostics Ltd. (VPTDF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like VentriPoint Diagnostics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is VentriPoint Diagnostics Ltd.'s ROE?
How is the ROE calculated for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the highest ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the 3-year average ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the 5-year average ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
How does the current ROE for VentriPoint Diagnostics Ltd. (VPTDF) compare to its historical average?